Skip to main content

Table 1 Demographic and baseline characteristics of the intent-to-treat population

From: Safety and tolerance assessment of milk fat globule membrane-enriched infant formulas in healthy term Chinese infants: a randomised multicenter controlled trial

 

MFGM-enriched formula (n = 108)

Standard-formula (n = 104)

P

Breast-fed Reference (n = 206)

P

MF vs SF

Overall

Male, n (%)

53 (49.1)

49 (47.1)

1.00

103 (50.0)

0.89

Caesarean birth (%)

45 (41.7)

36 (34.6)

0.90

67 (32.5)

0.17

Any sibling (%)

74 (68.5)

72 (66.3)

1.00

107 (51.9)

0.002

Maternal disease during pregnancy (%)

7 (6.4)

9 (8.6)

1.00

12 (5.8)

0.90

Weight at birth 1(g)

3206.9 ± 356.6

3241.9 ± 394.0

1.00

3284.1 ± 334.6

0.18

Length at birth (cm)

49.5 ± 1.7

49.6 ± 1.9

1.00

49.5 ± 1.4

0.85

BMI at birth (kg/m2)

13.1 ± 1.2

13.2 ± 1.3

1.00

13.4 ± 1.1

0.08

Head circumference at birth (cm)

33.9 ± 1.2

33.9 ± 1.4

1.00

34.2 ± 1.2

0.09

Any disease after delivery (%)

7 (6.5)

4 (3.8)

0.68

0 (0.0)

0.002

Maternal age (y)

29.4 ± 5.0

29.7 ± 5.0

1.00

27.7 ± 4.6

0.001

  1. 1 Data are means ± standard deviation or number (%). A general linear model, group and sex as fixed effects, group by sex interaction and site as a random factor